Internal Medicine, Medical Oncology · Tampa, FL
NPI
1164474615
Since 2006
Specialty
Internal Medicine, Medical Oncology
Code 207RX0202X
Group practices
2
Medicare group memberships
Hospitals
1
Hospital affiliations
3402 W Dr Martin Luther King Jr Blvd
Tampa, FL, 33607
Phone (813) 875-3950
Groups this clinician bills Medicare through
Medicare paid, 2024
$934K
67,900 services
Medicare patients, 2024
412
Average age 76
Drug cost, 2024
$2.4M
1,419 prescriptions
Company payments, 2025
$2,432
From 29 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Rafael W Blanco was code Q0138 (injection, ferumoxytol, for treatment of iron deficiency anemia, 1 mg (non-esrd use)), 20,910 times for 20 patients. In total Rafael W Blanco billed 67,900 services in 116 codes, and Medicare paid $934K.
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2026-03-24.
| Code | Setting | Services | Patients | Paid per service | Medicare paid |
|---|
| Q0138 Injection, ferumoxytol, for treatment of iron deficiency anemia, 1 mg (non-esrd use) | Office | 20,910 | 20 | $0.28 | $5,885 |
| J0885 Injection, epoetin alfa, (for non-esrd use), 1000 units | Office | 3,850 | 23 | $6.21 | $24K |
| 36415 Venipuncture Blood Collection | Office | 876 | 303 | $8.64 | $7,569 |
| 85025 Blood Count | Office | 868 | 307 | $7.61 | $6,605 |
| J1100 Injection, dexamethasone sodium phosphate, 1 mg | Office | 542 | 15 | $0.09 | $46.52 |
| 99214 Office E&M - Established | Office | 365 | 157 | $91.47 | $33K |
| 96372 Injection Administration | Office | 274 | 73 | $10.38 | $2,843 |
| 96375 Injection Administration | Office | 229 | 32 | $11.43 | $2,618 |
| 99213 Office E&M - Established | Office | 195 | 143 | $63.78 | $12K |
| 96413 Chemotherapy Administration | Office | 116 | 27 | $94.41 | $11K |
| J3420 Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg | Office | 91 | 29 | $0.93 | $84.99 |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Office | 89 | 65 | $12.72 | $1,132 |
| 96365 Intravenous Infusion, Hydration | Office | 85 | 39 | $44.76 | $3,804 |
| J1200 Injection, diphenhydramine hcl, up to 50 mg | Office | 70 | 21 | $0.60 | $42.31 |
| 96367 Intravenous Infusion, Hydration | Office | 49 | 17 | $20.37 | $998 |
By year: 2022 $1.5M for 94,767 services; 2023 $1.3M for 95,923 services; 2024 $934K for 67,900 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 36415 Venipuncture Blood Collection | 876 | 303 | $8.64 | $7,569 |
| 85025 Blood Count | 868 | 307 | $7.61 | $6,605 |
| 85045 Blood Count | 33 | 27 | $3.91 | $129 |
Medicare prescription drug claims, 2024
In 2024, the drug Rafael W Blanco prescribed most often to Medicare patients was Letrozole, with 91 prescriptions and refills. In total Rafael W Blanco wrote 1,419 Medicare prescriptions that cost $2.4M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Letrozole Generic | 91 | 188 | 26 | $1,991 |
| Gabapentin Generic | 91 | 103 | 35 | $661 |
| Oxycodone-Acetaminophen Oxycodone Hcl/Acetaminophen | 75 | 75 | 22 | $2,513 |
| Ondansetron Odt Ondansetron | 74 | 74 | 32 | $1,277 |
| Lorazepam Generic | 59 | 66 | 14 | $482 |
| Alprazolam Generic | 58 | 67 | 20 | $570 |
| Prednisone Generic | 55 | 61 | 15 | $342 |
| Tramadol Hcl Generic | 48 | 48 | 32 | $343 |
| Oxycodone Hcl Generic | 45 | 45 | 11 | $863 |
| Revlimid Lenalidomide | 38 | 38 | Under 11 | $556K |
| Hydroxyurea Generic | 31 | 63 | Under 11 | $1,308 |
| Imatinib Mesylate Generic | 28 | 28 | Under 11 | $19K |
| Megestrol Acetate Generic | 28 | 29 | 17 | $1,114 |
| Dexamethasone Generic | 26 | 28 | Under 11 | $428 |
| Exemestane Generic | 25 | 42 | Under 11 | $2,890 |
Brand drugs: - claims; generic drugs: 1,157 claims; opioid claims: 240.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Rafael W Blanco $2,432 ($2,432 in general payments such as food, travel and fees) from 29 companies. The largest payer was Daiichi Sankyo Inc. with $218.
| Company | Payments | Amount |
|---|---|---|
| Daiichi Sankyo Inc. 4568.T | 4 | $218 |
| Abbvie Inc. ABBV | 4 | $194 |
| Novartis Pharmaceuticals Corporation NVS | 9 | $188 |
| Gilead Sciences, Inc. GILD | 8 | $181 |
| Jazz Pharmaceuticals Inc. JAZZ | 2 | $162 |
| Regeneron Healthcare Solutions, Inc. REGN | 5 | $147 |
| AstraZeneca Pharmaceuticals LP AZN | 2 | $143 |
| Sanofi US Services Inc. SNY | 1 | $132 |
| Pfizer Inc. PFE | 5 | $113 |
| GlaxoSmithKline, LLC. GSK | 4 | $98.52 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.